Science to Access

Jen van der MeerUncategorized

For scientific founders, discovery is just the beginning. But moving a breakthrough from the lab into the world is an entirely different challenge.

Commercialization isn’t just a necessity—it’s a powerful mechanism for impact. When done well, it ensures that innovation reaches people, scales effectively, and sustains itself over time. But not all commercialization models lead to the full realization of a scientific breakthrough.

Some paths create gaps in access or long-term sustainability, limiting how far an innovation can go. Founders who want to see the full impact of their work often need to think beyond just launching a company—they need to consider:

  • How will this reach the people, systems, and ecosystems it was meant to benefit?
  • What market structures, funding models, or policy levers will enable both growth and access?
  • How do I commercialize in a way that ensures long-term contribution?

Commercialization as a Contribution Strategy

The most effective scientific founders don’t just bring a product to market—they design commercialization models that reinforce their broader impact. This means making intentional choices about:

Market Entry & Scaling

  • Choosing between licensing, partnerships, direct commercialization, or hybrid models based on how the science scales best.
  • Designing for early adopter markets that create proof points while keeping long-term accessibility in mind.
  • Ensuring that regulatory and reimbursement create rather than limit options for availability post-approval.

Capital & Ownership Structures

  • Choosing between licensing, partnerships, direct commercialization, or hybrid models based on how the science scales best.
  • Designing for early adopter markets that create proof points while keeping long-term accessibility in mind.
  • Ensuring that regulatory and reimbursement create rather than limit options for availability post-approval.

Access & Systemic Contribution

  • Integrating tiered pricing, licensing structures, or pooled procurement models to ensure affordability.
  • Embedding innovations into regional health and environmental ecosystems to drive broader benefits.
  • Aligning commercialization with policy shifts, infrastructure investments, and collaborative models that maximize impact.

Designing for Scale and Long-Term Impact

For scientific founders, commercialization isn’t just about bringing an idea to market—it’s about ensuring the business model, capital strategy, and contribution model reinforce each other.

At Reason Street, we work with founders to design commercialization pathways that balance growth, investment, and contribution—so that your science not only succeeds in the market but delivers its full potential to society.

If you’re navigating this challenge, let’s talk.